گریندکس

Also known as Grindeks AS, Grindeks, AS

JSC Grindex (branded as Grindex), or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021, Grindex exported products to more than 90 countries.

Key facts

Company.name: AS Grindex
Company.logo: Grindeks_Logo.svg
Company.image: Grindeks Latvia.JPG
Company.trading_name: Grindex
Company.industry: Pharmaceuticals
Company.founded: 1946
Company.hq_location: 53 Krustpils St
Company.hq_location_city: Riga
Company.hq_location_country: Latvia
Company.key_people: Kirovs Lipmans(Chairman of the Council), Juris Hmelnickis (CEO), Janis Romanovskis (Chief Finance and Administrative Officer), Andrejs Liberts, (Commercial director)
Company.products: Mildronate; Ftorafur
Company.production: Pharmaceuticals
Company.revenue: 187 million EUR
Company.revenue_year: 2020
Company.owner: Liplat Holding, Ltd.
Company.num_employees: 1498
Company.num_employees_year: 2021
Company.subsid: JSC Kalceks, JSC Tallinn Pharmaceutical Plant, HBM Pharma Ltd.